Effect of Empagliflozin on Liver Steatosis and Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease Without Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial
Titel:
Effect of Empagliflozin on Liver Steatosis and Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease Without Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial
Auteur:
Taheri, Hoda Malek, Mojtaba Ismail-Beigi, Faramarz Zamani, Farhad Sohrabi, Masoudreza Reza babaei, Mohammad Khamseh, Mohammad E.